Radial Extracorporeal Shock Wave Treatment for Chronic Plantar Fasciopathy
CompletedNot applicableNCT02679521
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Radial extracorporeal shock wave therapy (rESWT) has been previously demonstrated as an efficient treatment option for heel pain associated with chronic proximal plantar fasciitis when administered in three sessions. The present study tested the hypothesis that heel pain associated with chronic proximal plantar fasciitis can also be treated successfully with rESWT when only two treatment sessions are performed.
Study details
- Official title
- The Effectiveness of Extracorporeal Shock Wave Therapy for Patients With Plantar Fasciitis Who Satisfy a Clinical Prediction Rule
- Conditions
- Fasciitis, Plantar
- Interventions
- Device: ESWT
- Device: Placebo
- Sponsor
- Prof. Dr Mahmoud Ibrahim Ibrahim
- Organization
- Rocky Mountain University of Health Professions
- Start date
- 2007-10
- Primary completion
- 2010-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults over the age of 18 years * Diagnosis of painful heel syndrome by clinical examination, with the following positive clinical signs: (i) pain in the morning or after sitting a long time; (ii) local pain where the fascia attaches to the heel; and (iii) increasing pain with extended walking or standing for more than 15 minutes * History of six months of unsuccessful conservative treatment * Therapy free period of at least four weeks before referral * Signed informed consent Exclusion Criteria: * Bilateral plantar fasciitis * Dysfunction of foot or ankle (for example, instability) * Arthrosis or arthritis of the foot * Infections or tumors of the lower extremity * Neurological abnormalities, nerve entrapment (for example, tarsal tunnel syndrome) * Vascular abnormality (for example, severe varicosities, chronic ischemia) * Operative treatments of the heel spur * Hemorrhagic disorders and anticoagulant therapy * Pregnancy * Diabetes
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02679521